Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Ann N Y Acad Sci. 2022 May 17;1514(1):21–33. doi: 10.1111/nyas.14798

Figure 3.

Figure 3.

Occludin downregulation in inflammatory bowel disease is accompanied by reduced caspase-3 expression. (A) Hematoxylin-eosin (H&E) and immunofluorescent staining of occludin (green) and caspase-3 (green) in ileal biopsies from healthy control subjects and Crohn’s disease patients. E-cadherin (red) and nuclei (blue) are shown for reference. Bar = 50 μm. (B) Quantitative morphometry of occludin, caspase-3, and E-cadherin staining intensity within the intestinal epithelium. (C) Caspase-3 expression correlates with occludin expression (r2 = 0.76). Originally published in Kuo et al.101